ArticleFrontiers in pharmacology2022

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers.

Ruijia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.